[Expression of nicotinamide adenine dinucleotide phosphate-reduced oxidase-4/reactive oxygen species and cystathionine-γ-lyase/hydrogen sulfide in patients with chronic obstructive pulmonary disease-related pulmonary hypertension]

Zhonghua Nei Ke Za Zhi. 2019 Oct 1;58(10):770-776. doi: 10.3760/cma.j.issn.0578-1426.2019.10.009.
[Article in Chinese]

Abstract

Objective: To observe the levels of serum reactive oxygen species (ROS) and hydrogen sulfide(H(2)S) in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD), and nicotinamide adenine dinucleotide phosphate-reduced (NADPH) oxidase 4 (NOX4) and cystathionine-γ-lyase (CSE) in lung tissue of patients with stable chronic obstructive pulmonary disease (COPD). Methods: (1) A total of 60 patients with AECOPD admitted to the Department of Respiratory Medicine at Ningxia Hui People's Hospital from November 2015 to December 2016 were recruited. According to the results of pulmonary function and echocardiography, the participants were divided into AECOPD-related pulmonary hypertension (PH) group(A) and AECOPD non-PH group (B).Other 30 healthy subjects were selected as the control group (C).Serum ROS and H(2)S of group A, B and C were detected by enzyme-linked immunosorbent assay (ELISA).(2)The lung tissues of patients undergoing lobectomy for lung cancer from November 2012 to April 2017 were collected, who were divided into COPD-related PH group (D), COPD non-PH group (E) and negative control (F). The expression of NOX4 and CSE protein in lung tissue was detected by immunohistochemistry and the thickness of pulmonary arteriole wall was measured. Results: (1)The serum ROS level in group A was higher than group B and C which were (613.52±69.66)IU/ml,(565.76±71.33)IU/ml, (294.63±60.39)IU/ml, respectively with that in group B higher than that in group C (P<0.05). Serum H(2)S level in group A was lower than group B and C, with that in group B lower than group C [(18.59±5.50) nmol/ml, (20.49±4.97) nmol/ml, (38.03±4.43) nmol/ml, respectively P<0.05]. ROS level was positively correlated with pulmonary systolic pressure (PASP) (r=0.59, P<0.05), H(2)S level was negatively correlated with PASP(r=-0.62, P<0.05).(2)The lung tissue expression of NOX4 in group D was higher than group E and F (P<0.05), which were 0.08±0.01,0.06±0.01,0.03±0.01, respectively,while the level of NOX4 in group E was higher than group F (P<0.05). The expression of CSE between group D, E and F were all significantly different (P<0.05),which were 0.03±0.01, 0.07±0.02,0.12±0.02, respectively.(3)Smooth muscle thickness of pulmonary arterioles as a percentage of vascular diameter (WT%) between group D, E and F was all different(P<0.05), which were (40.58±6.63)%,(36.87±5.60)%,(31.27±6.24)%, respectively; so was smooth muscle area of pulmonary arterioles as a percentage of total vascular area(WA%) with (32.33±6.27)%, (30.20±5.28)%, (25.20±4.31)%, respectively (P<0.05). (4)The expression of NOX4 was positively correlated with WT% and WA%, r was 0.81 and 0.66, respectively (P<0.05). The expression of CSE was negatively correlated with WT% and WA%, r was -0.55 and -0.39 respectively (P<0.05). Conclusions: NOX4/ROS and CSE/H(2)S signaling pathways may play an important role in the pathogenesis of COPD related PH.

目的: 探讨慢性阻塞性肺疾病(COPD)急性加重期患者血清活性氧(ROS)、硫化氢(H(2)S)水平,及COPD稳定期患者肺组织中还原型烟酰胺腺嘌呤二核苷酸(NADPH)氧化酶-4(NOX4)、胱硫醚-γ-裂解酶(CSE)表达及其意义。 方法: (1)选2015年11月至2016年12月在宁夏回族自治区人民医院呼吸科住院的COPD急性加重患者60例,根据是否合并肺动脉高压(PH)分为COPD急性加重合并PH组和COPD急性加重未合并PH组,另选同期健康体检者30例为健康对照组,采用酶联免疫法测3组受试者血清ROS、H(2)S水平。(2)收集2012年11月至2017年4月在宁夏回族自治区人民医院心胸外科因肺癌行肺叶切除42例患者的肺组织,根据是否合并PH分为COPD稳定期合并PH组和COPD稳定期未合并PH组、对照组,免疫组化法测3组患者肺组织NOX4、CSE表达,并观察肺小动脉壁厚度。 结果: (1)COPD急性加重合并PH组患者血清ROS水平[(613.52±69.66)IU/ml]高于COPD急性加重未合并PH组[(565.76±71.33)IU/ml]、健康对照组[(294.63±60.39)IU/ml],COPD急性加重未合并PH组患者血清ROS水平高于健康对照组(P<0.05)。COPD急性加重合并PH组患者血清H(2)S水平[(18.59±5.50)nmol/ml]低于COPD急性加重未合并PH组[(20.49±4.97)nmol/ml]、健康对照组[(38.03±4.43)nmol/ml],COPD急性加重未合并PH组患者血清H(2)S水平低于健康对照组(P<0.05)。ROS水平与肺动脉收缩压(PASP)呈正相关(r=0.59,P<0.05),H(2)S水平与PASP呈负相关(r=-0.62,P<0.05)。(2)COPD稳定期合并PH组肺组织NOX4表达(0.08±0.01)高于COPD稳定期未合并PH组(0.06±0.01)、对照组(0.03±0.01),COPD稳定期未合并PH组肺组织NOX4表达高于对照组(P<0.05)。COPD稳定期合并PH组肺组织CSE表达(0.03±0.01)低于COPD稳定期未合并PH组(0.07±0.02)、对照组(0.12±0.02),COPD稳定期未合并PH组肺组织CSE表达低于对照组(P<0.05)。COPD稳定期合并PH组WT%[(40.58±6.63)%]高于COPD稳定期未合并PH组[(36.87±5.60)%]、对照组[(31.27±6.24)%],COPD稳定期未合并PH组WT%高于对照组(P<0.05)。COPD稳定期合并PH组WA%[(32.33±6.27)%]高于COPD稳定期未合并PH组[(30.20±5.28)%]、对照组[(25.20±4.31)%],COPD稳定期未合并PH组WA%高于对照组(P<0.05)。NOX4表达与WT%、WA%呈正相关(r值分别为0.81、0.66,P值均<0.05),CSE表达与WT%、WA%呈负相关(r值分别为-0.55、-0.39,P值均<0.05)。 结论: NOX4/ROS和CSE/H(2)S信号通路在COPD合并PH的发病机制中可能起重要作用。.

Keywords: Cystathionine-γ-lyase; Hydrogen sulfide; Hypertension, pulmonary; Nicotinamide adenine dinueleotide phosphate-reduced oxidase 4; Pulmonary disease, chronic obstructive; Reactive oxygen species.

MeSH terms

  • Case-Control Studies
  • Cystathionine / metabolism*
  • Cystathionine gamma-Lyase / metabolism*
  • Humans
  • Hydrogen Sulfide / blood*
  • Hypertension, Pulmonary / blood
  • Hypertension, Pulmonary / metabolism*
  • Hypertension, Pulmonary / physiopathology*
  • NADPH Oxidase 4 / metabolism*
  • Oxidoreductases
  • Pulmonary Disease, Chronic Obstructive / blood
  • Pulmonary Disease, Chronic Obstructive / metabolism*
  • Pulmonary Disease, Chronic Obstructive / physiopathology*
  • Reactive Oxygen Species / blood*

Substances

  • Reactive Oxygen Species
  • Cystathionine
  • Oxidoreductases
  • NADPH Oxidase 4
  • Cystathionine gamma-Lyase
  • Hydrogen Sulfide